Hiroki Nagata

No ORCID on file · 6 papers in corpus · active 2021-2025

Study types

  • other 4
  • article 2

Condition tags

  • endometriosis 3
  • adenomyosis 3
  • mesh:D004715 2
  • endometrioma 1
other 2025
P2X4 receptor mediates macrophage infiltration leading to endometriotic cyst epithelium proliferation and hyperalgesia in mouse model
F&S science ·doi:10.1016/j.xfss.2024.10.007

OBJECTIVE: To evaluate the effects of a P2X4 receptor (P2X4R)-specific antagonist on murine endometriotic-like lesions and human endometriotic stromal cells. DESIGN: Experimental study using an in vivo mouse endometriosis model and in vitr…

other 2025
Prediction of Periureteral Adhesions by Drop Infusion Pyelography Before Laparoscopic Hysterectomy: A Retrospective Study
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.70141

AIM: To identify the predictors for periureteral adhesions preoperatively. METHODS: Preoperative predictors for periureteral adhesions were evaluated in 407 patients who underwent laparoscopic hysterectomy (LH) for benign uterine diseases …

other 2024
Corrigendum to "Increased chemokine ligand 26 expression and its involvement in epithelial-mesenchymal transition in the endometrium with adenomyosis" [Volume 52, Issue 9 (2023) 102645]
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2024.102741
other 2024
Role of tenascin C in lesion formation in early peritoneal endometriosis
F&S science ·doi:10.1016/j.xfss.2023.12.004

OBJECTIVE: To identify cytokines or extracellular matrix components that contribute to adhesion to, and invasion of, the peritoneum, proximal to lesions in the early phase of endometriosis. DESIGN: Laboratory-based study. SETTING: Univers…

article 2023
Increased chemokine ligand 26 expression and its involvement in epithelial-mesenchymal transition in the endometrium with adenomyosis
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2023.102645
article 2021
A controlled clinical trial comparing potent progestins, LNG‐IUS and dienogest, for the treatment of women with adenomyosis
Reproductive medicine and biology ·doi:10.1002/rmb2.12408

PURPOSE: To evaluate the efficacy of two progestins, levonorgestrel intrauterine system (LNG-IUS) and dienogest (DNG), for adenomyosis. METHODS: = 81) groups as a controlled clinical trial for 72 months. Participants were classified by thre…